Business Impact Risk from COVID-19
First written in FY2020. 5 of 15 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2025: 5 of 18 companies on the "Worse" side.
15 other companies' latest entry also says "Dropped".
- FY2024DroppedAnnual report
「The Group's sales and production sites in Japan are located throughout the country. If a large-scale disaster occurs in any of these areas, or if a large-scale infectious disease or other illness spreads, business activities may be seriously disrupted, potentially affecting the Group's performance.」
COVID-19 is no longer described as a standalone risk because it has been generalized as “large-scale infectious diseases and other events”; the standalone COVID-19 risk description has therefore been removed. - FY2024-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that, regarding business-impact risks from COVID-19, there have been no new developments or material changes to existing risks. - FY2024-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that, regarding business-impact risks from COVID-19, there have been no new developments or material changes to existing risks. - FY2024-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that, regarding business-impact risks from COVID-19, there have been no new developments or material changes to existing risks. - FY2023MitigatedAnnual report
「Regarding the outlook for Japan's economy, a recovery is expected under the conditions of living with COVID-19, partly as a result of various policy measures. However, close attention must be paid to the impact of recession risks stemming from global monetary tightening and other factors, rising prices, supply-side constraints, and volatility in financial and capital markets.」
Regarding the economic impact of COVID-19, the Company has shifted to language stating that an economic recovery is expected under the conditions of living with COVID-19, while noting that risks such as rising prices and supply constraints remain. - FY2023-Q3MitigatedAnnual report
「Although Japan's economy during the third quarter consolidated cumulative period showed signs of recovery under the conditions of living with COVID-19, instability in the international situation continued, and the effects of supply-side constraints and higher prices caused by the weaker yen began to emerge.」
The Company states that Japan's economy showed signs of recovery from the difficult conditions caused by COVID-19, and has softened its description of the disease's economic impact compared with the previous quarter. Meanwhile, the effects of supply constraints and higher prices have emerged. - FY2023-Q2MitigatedAnnual report
「Although Japan's economy during the second quarter consolidated cumulative period showed signs of recovery from the difficult conditions caused by COVID-19, instability in the international situation continued, raising concerns about supply-side constraints and the impact of higher prices caused by the weaker yen.」
The Company states that Japan's economy showed signs of recovery from the difficult conditions caused by COVID-19, and has softened its description of the disease's economic impact compared with the previous quarter. - FY2023-Q1WorsenedAnnual report
「During the cumulative first quarter under review, the Japanese economy showed signs of recovery, but the situation remained unpredictable, with concerns about a renewed spread of COVID-19 and prolonged instability in international conditions, as well as increasing risks of a downturn resulting from supply constraints, rising raw material prices and volatility in financial and capital markets.」
The Company continues to highlight significant business-impact risks, including supply constraints and rising raw material prices, amid concerns about the renewed spread of COVID-19 and prolonged instability in the international situation. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter under review, the Japanese economy showed signs of recovery as the severe conditions caused by COVID-19 gradually eased, but the situation remained unpredictable, with increasing risks of a downturn resulting from supply-side constraints, trends in raw material prices and a renewed spread of infections.」
The Company states that, although the difficult conditions caused by COVID-19 have gradually eased, downside risk from a renewed spread of infections has increased. - FY2022-Q2WorsenedAnnual report
「During the cumulative second quarter under review, the Japanese economy remained in a difficult situation due to the impact of COVID-19. Although there were signs of recovery resulting from progress in vaccinations, the effects of various policies and improvements in overseas economies, the situation remained unpredictable, including because of the increasing risk of a downturn caused by impacts transmitted through supply chains.」
The Company states that difficult economic conditions caused by COVID-19 continue and that the resulting impact through the supply chain is increasing downside risk. - FY2022-Q1WorsenedAnnual report
「During the cumulative first quarter under review, the Japanese economy remained in a difficult situation due to the impact of COVID-19. Although there were signs of recovery resulting from progress in vaccinations, the effects of various policies and improvements in overseas economies, uncertainty about the outlook was increasing.」
The Company states that difficult economic conditions caused by COVID-19 continue and that the outlook has become more uncertain. - FY2021-Q3WorsenedAnnual report
「Although personal consumption, exports and production showed signs of recovery as a result of various measures, there were signs of a renewed spread of infections, increasing the risk of a downturn in the domestic and overseas economies.」
The Company states that the risk of a downside in domestic and overseas economies has increased as COVID-19 has shown signs of spreading again. Meanwhile, it states in the business and other risks section that there are no new risks. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, economic activity in Japan stagnated significantly as COVID-19 spread globally and a state of emergency was declared temporarily in Japan. Although social and economic activity was gradually restarted after the declaration was lifted, and personal consumption, exports and production showed signs of recovery, concerns about a renewed spread of infections remained unresolved and the outlook continued to be difficult to assess.」
The Company states that economic stagnation caused by COVID-19 and concerns about a renewed spread of the disease continue. - FY2021-Q1MaterialisedAnnual report
「During the first quarter consolidated cumulative period, all product groups were affected by COVID-19, and sales for each were below the previous year's level.」
The impact of COVID-19, which had been described in the previous fiscal year as potentially affecting performance, emerged in the first quarter as sales for all product groups fell below the year-earlier period. - FY2020First statedAnnual report
「The novel coronavirus disease is spreading worldwide and may affect the performance of the Group, but as of the filing date, it is difficult to estimate the impact objectively.」
The global spread of COVID-19 is identified as a new risk that may affect performance. The Company states that the amount of the impact is difficult to estimate objectively as of the filing date.